We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$919M 1.74%
5,262,747
-1,278,393
-20% -$215M
MSFT icon
2
Microsoft
MSFT
$2.84T
$757M 1.43%
2,454,881
-1,817,655
-43% -$547M
AMZN icon
3
Amazon
AMZN
$2.5T
$707M 1.34%
4,334,980
-2,882,860
-40% -$445M
UNH icon
4
UnitedHealth
UNH
$382B
$685M 1.3%
1,344,182
+482,384
+56% +$233M
SPGI icon
5
S&P Global
SPGI
$126B
$632M 1.2%
1,541,300
+664,425
+76% +$271M
WFC icon
6
Wells Fargo
WFC
$261B
$605M 1.15%
12,487,918
+8,977,357
+256% +$480M
AVGO icon
7
Broadcom
AVGO
$1.82T
$558M 1.06%
8,865,800
+4,595,750
+108% +$273M
MRK icon
8
Merck
MRK
$324B
$557M 1.05%
6,785,568
+6,746,481
+17,260% +$532M
ABNB icon
9
Airbnb
ABNB
$83.7B
$467M 0.89%
2,720,836
+1,647,281
+153% +$262M
V icon
10
Visa
V
$677B
$450M 0.85%
2,028,644
+2,013,238
+13,068% +$435M
VZ icon
11
Verizon
VZ
$194B
$440M 0.83%
8,645,695
+6,040,148
+232% +$320M
BSX icon
12
Boston Scientific
BSX
$65.8B
$423M 0.8%
9,540,382
+3,182,702
+50% +$138M
CMCSA icon
13
Comcast
CMCSA
$79.1B
$412M 0.78%
8,805,174
+1,234,053
+16% +$59.4M
TSLA icon
14
Tesla
TSLA
$1.24T
$359M 0.68%
1,000,305
+255,420
+34% +$79.6M
JNJ icon
15
Johnson & Johnson
JNJ
$635B
$348M 0.66%
1,963,295
-462,856
-19% -$78.8M
GOOGL icon
16
Alphabet (Google) Class A
GOOGL
$3.91T
$323M 0.61%
2,320,180
-3,355,020
-59% -$456M
IBKR icon
17
Interactive Brokers
IBKR
$40.9B
$296M 0.56%
17,973,976
+536,212
+3% +$9.23M
BKNG icon
18
Booking.com
BKNG
$138B
$295M 0.56%
3,144,750
+1,929,650
+159% +$180M
WMT icon
19
PUT
Walmart Inc
WMT
$871B
$293M 0.56%
5,904,300
+5,757,900
+3,933% +$270M
SBUX icon
20
Starbucks
SBUX
$118B
$285M 0.54%
3,137,854
+2,595,828
+479% +$245M
BHVN
21
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$285M 0.54%
2,401,284
-397,173
-14% -$49.5M
CFG icon
22
Citizens Financial Group
CFG
$30.4B
$270M 0.51%
5,958,531
+2,079,246
+54% +$107M
TRU icon
23
TransUnion
TRU
$14.8B
$269M 0.51%
2,599,037
+206,089
+9% +$20.9M
OVV icon
24
Ovintiv
OVV
$17.5B
$263M 0.5%
4,870,110
+930,750
+24% +$40.1M
BIO icon
25
Bio-Rad Laboratories Class A
BIO
$8.42B
$263M 0.5%
467,343
+133,973
+40% +$80.8M

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.